Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Bukwang Pharmaceutical Revenue

Bukwang Pharmaceutical had revenue of 56.99B KRW in the quarter ending June 30, 2026, with 33.84% growth. This brings the company's total for the last twelve months to 215.09B, up 20.05% year-over-year. In the year 2025, Bukwang Pharmaceutical had annual revenue of 200.71B with 25.38% growth. That makes Bukwang Pharmaceutical the 19,097th largest company in the world by revenue and 989th in South Korea.

• Revenue (ttm): 215.09B
• Revenue Growth: +20.05%
• P/S Ratio: 1.76
• Revenue / Employee: 341.42M
• Employees: 630
• Market Cap: 378.87B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical 191.39B 94.7%
• Research and Development Department 10.69B 5.3%

By Geography

Chart

• South Korea 190.38B 94.9%
• Overseas 10.34B 5.1%

Fiscal year ended Dec 31, 2025 See the full Bukwang Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	200.71B	40.63B	25.38%
Dec 31, 2024	160.09B	34.16B	27.13%
Dec 31, 2023	125.93B	-64.98B	-34.04%
Dec 31, 2022	190.91B	8.42B	4.61%
Dec 31, 2021	182.49B	12.83B	7.56%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error